Incidence of choroidal neovascularization in the fellow eye in the comparison of age-related macular degeneration treatments trials.
about
Anti-vascular endothelial growth factor for neovascular age-related macular degenerationGuidelines for the Management of Wet Age-Related Macular Degeneration: Recommendations from a Panel of Greek ExpertsPseudodrusen and Incidence of Late Age-Related Macular Degeneration in Fellow Eyes in the Comparison of Age-Related Macular Degeneration Treatments Trials.Estimation of the need for bilateral intravitreal anti-VEGF injections in clinical practice.What is the evidence for systemic effects of intravitreal anti-VEGF agents, and should we be concerned?A genome-wide association study identified a novel genetic loci STON1-GTF2A1L/LHCGR/FSHR for bilaterality of neovascular age-related macular degeneration.Cost-effectiveness of treating wet age-related macular degeneration at the Kuopio University Hospital in Finland based on a two-eye Markov transition model.ApoA-I Mimetic Peptide 4F Reduces Age-Related Lipid Deposition in Murine Bruch's Membrane and Causes Its Structural Remodeling.Intravitreal Injection of Anti-vascular Endothelial Growth Factor Agents for Ocular Vascular Diseases: Clinical Practice Guideline.Prevalence of Subclinical CNV and Choriocapillaris Nonperfusion in Fellow Eyes of Unilateral Exudative AMD on OCT AngiographyLow incidence of choroidal neovascularization following subthreshold diode micropulse laser (SDM) in high-risk AMD
P2860
Q24194251-C83E8518-200F-4802-99C8-B5986AC2E648Q26749615-F8E7F290-3899-4AF5-9412-F56023DDA768Q35978361-96B76D4E-C01B-4741-B50B-26887D58F33DQ36099741-A3EE121A-3E12-415B-8E30-EF7DDF6E2BD4Q38170235-3D96801A-A9D5-4E88-9CAF-59A2CD58587CQ41242933-9096E882-E633-4F2E-AC49-4593A1B9B514Q47661928-F704D2CD-39DF-4EE7-BE10-2AFAB2E3EA9CQ47708481-C1200E42-7D2F-4913-A90D-51A0F3CF182AQ54942391-B794EBF4-8726-42B3-8D36-532B4DE5D3A6Q57063000-3BD2193D-447D-4A2F-B6DF-701E9D1785DFQ58715760-4C149236-B9B6-4B99-A657-ECD47C9D2CBC
P2860
Incidence of choroidal neovascularization in the fellow eye in the comparison of age-related macular degeneration treatments trials.
description
2013 nî lūn-bûn
@nan
2013 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Incidence of choroidal neovasc ...... egeneration treatments trials.
@ast
Incidence of choroidal neovasc ...... egeneration treatments trials.
@en
Incidence of choroidal neovasc ...... egeneration treatments trials.
@nl
type
label
Incidence of choroidal neovasc ...... egeneration treatments trials.
@ast
Incidence of choroidal neovasc ...... egeneration treatments trials.
@en
Incidence of choroidal neovasc ...... egeneration treatments trials.
@nl
prefLabel
Incidence of choroidal neovasc ...... egeneration treatments trials.
@ast
Incidence of choroidal neovasc ...... egeneration treatments trials.
@en
Incidence of choroidal neovasc ...... egeneration treatments trials.
@nl
P2093
P2860
P1433
P1476
Incidence of choroidal neovasc ...... degeneration treatments trials
@en
P2093
Alessandro A Castellarin
Ankoor R Shah
Comparison of Age-Related Macular Degeneration Treatments Trials (CATT Research Group)
Daniel B Roth
Daniel F Martin
Jiayan Huang
Juan E Grunwald
Maureen G Maguire
Revell W Martin
Robert L Avery
P2860
P304
P356
10.1016/J.OPHTHA.2013.03.017
P50
P577
2013-05-22T00:00:00Z